Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Recommendation of final cum special dividend

Akums Drugs has recommended a final dividend of Rs. 1.00 per share and a special dividend of Rs. 2.00 per share for FY2026, totaling Rs. 3 per equity share (face value Rs. 2 each). The record date is July 3, 2026. The company reported standalone profit after tax of Rs. 1,116.40 million for FY2026, down from Rs. 1,609.98 million in FY2025 (approximately 31% decline). Despite the profit decline, the board approved these dividends subject to shareholder approval at the 22nd AGM on July 10, 2026. The auditors flagged an ongoing Income Tax Department search and seizure operation from January 2025 and subsequent show cause notices as an emphasis of matter, though no material adjustments were made to the financial results.